Clinical Trial Update: Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans [NA]

View source ↗

Summary

The clinical trial evaluated how exenatide (Byetta) influences intestinal and hepatic lipoprotein particle production in adults with hyperlipidemia; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• BYETTA (Exenatide)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Hyperlipidemia | NA | Status: COMPLETED